Aravind Kumar Rengan

Affiliation: University of California, Los Angeles
Institution: University of California, Los Angeles
ORCID: 0000-0003-3994-6760
External IDs: ResearcherID: O-2043-2014 | Scopus Author ID: 55485470900 | SciProfiles: 2426364 | Scopus Author ID: 58158015000 | Loop profile: 1729080
Email: aravind.rengan@ucla.edu
Works: 45, Cited by: 1023, H-index: 15
Leading research in nanomedicine and cancer theranostics at UCLA

Education

  • PhD in Biomedical Engineering, Stanford University (2008-2012)
  • MSc in Materials Science, Massachusetts Institute of Technology (2006-2008)

Research Interests

Keywords:
Nanomedicine Cancer Theranostics Biomaterials Drug Delivery AMR Analysis Phytomedicine
Topics:
Nanomedicine Cancer Theranostics Biomaterials Drug Delivery

Professional Links

Selected Publications

Targeted treatment improves RA outcomes
Chowdary P, Puppala ER, Putta CL, Maddila JR, Pulavarthy V, et al. Hyaluronic-Acid-Functionalized Tofacitinib Loaded Transethosomes for Targeted Drug Delivery in Rheumatoid Arthritis. ACS Appl Bio Mater. 2025;8:1594. doi:10.1021/acsabm.4c01743
PubMed DOI

Related Products